Adamas Pharmaceuticals Inc (25) | Human Resources (10)
Browse by Subcategory
Recent Contracts
-
Form of Performance Restricted Stock Unit Grant Notice and Award Agreement
(Filed With SEC on May 10, 2021)
-
Compensation arrangements with Executive Officers
(Filed With SEC on February 23, 2021)
-
Adamas Pharmaceuticals, Inc. Amended and Restated Executive Severance Plan
(Filed With SEC on February 23, 2021)
-
Extension to Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated July 15, 2020
(Filed With SEC on November 5, 2020)
-
Employment Offer by and between Adamas Pharmaceuticals, Inc. and Neil F. McFarlane, dated September 12, 2019
(Filed With SEC on November 7, 2019)
-
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Jennifer Rhodes, dated January 9, 2020
(Filed With SEC on May 7, 2020)
-
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated February 25, 2020
(Filed With SEC on May 7, 2020)
-
2020 Compensation actions with respect to Non-Employee Directors
(Filed With SEC on May 7, 2020)
-
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Alfred G. Merriweather, dated August 7, 2019
(Filed With SEC on November 7, 2019)
-
Transition, separation, and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Gregory T. Went, Ph.D., dated September 11, 2019
(Filed With SEC on November 7, 2019)